Sermorelin

Description

Sermorelin is a high-interest GHRH analog research peptide studied for its role in growth hormone-releasing hormone receptor signaling, pituitary GH release, and broader somatotropic-axis investigation. As the biologically active GHRH(1-29)-amide fragment, it is widely recognized in laboratory settings for relevance to endocrine signaling models, GH-pathway research, and peptide-based investigation of physiologic GH release patterns.

Supplied strictly for research use, sermorelin is intended for qualified professionals conducting analytical, laboratory, and educational investigation. This material is offered exclusively for controlled research environments and is not for human consumption, clinical use, or therapeutic application. Historically, sermorelin acetate was marketed in the U.S. as Geref, and FDA records show it was later determined not to have been withdrawn for reasons of safety or effectiveness.